Biogen plans to invest another $10 million in BioMotiv LLC

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

Pharmaceutical giant Biogen Inc. is expanding its relationship with BioMotiv LLC of Shaker Heights and plans to invest another $10 million in the therapeutic accelerator company associated with The Harrington Project for Discovery & Development at University Hospitals.

BioMotiv announced in a news release on Tuesday, Sept. 6, that its strategic partnership with Cambridge, Mass.-based Biogen now includes the ophthalmology therapeutic area, in addition to an existing neurology partnership.

Click here to read the complete article.

Originally published September 6, 2016.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: